Qichao Liao

Guangxi Key Laboratory Of Animal Breeding
Nanning, 530004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Aloesin improves metabolic associated fatty liver disease and obesity by targeting TGFBR1.

Aloesin improves metabolic associated fatty liver disease and obesity by targeting TGFBR1.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 21, 2025

MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy.

MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy.

Journal: Frontiers in nutrition

Published: July 09, 2025

Linarin alleviates high-fat diet-induced hepatic steatosis by inhibiting PDE4D and activating the cAMP/PKA/CREB pathway.

Linarin alleviates high-fat diet-induced hepatic steatosis by inhibiting PDE4D and activating the cAMP/PKA/CREB pathway.

Journal: Free radical biology & medicine

Published: May 17, 2025

PROTAC-mediated FTO protein degradation effectively alleviates diet-induced obesity and hepatic steatosis.

PROTAC-mediated FTO protein degradation effectively alleviates diet-induced obesity and hepatic steatosis.

Journal: International journal of biological macromolecules

Published: September 20, 2024

Dietary supplement of veratric acid alleviates liver steatosis and reduces abdominal fat deposition in broilers.

Dietary supplement of veratric acid alleviates liver steatosis and reduces abdominal fat deposition in broilers.

Journal: Poultry science

Published: July 22, 2024

Liver knockout of MCU leads to greater dysregulation of lipid metabolism in MAFLD.

Liver knockout of MCU leads to greater dysregulation of lipid metabolism in MAFLD.

Journal: Scientific reports

Published: May 16, 2024

7-Hydroxyflavone improves nonalcoholic fatty liver disease by acting on STK24.

7-Hydroxyflavone improves nonalcoholic fatty liver disease by acting on STK24.

Journal: Phytotherapy research : PTR

Published: January 23, 2024

Corrigendum to "Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/ SLC7A11 pathway" [Redox Biol. 68 (2023) 102963].

Corrigendum to "Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/ SLC7A11 pathway" [Redox Biol. 68 (2023) 102963].

Journal: Redox biology

Published: December 02, 2023

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.

Journal: Redox biology

Published: September 18, 2023

BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism.

BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism.

Journal: eLife

Published: September 15, 2023

5-Methoxyflavone ameliorates non-alcoholic fatty liver disease through targeting the cytochrome P450 1A1.

5-Methoxyflavone ameliorates non-alcoholic fatty liver disease through targeting the cytochrome P450 1A1.

Journal: Free radical biology & medicine

Published: December 13, 2022

Effects of Dietary Inclusion of β-Hydroxy-β-Methylbutyrate on Growth Performance, Fat Deposition, Bile Acid Metabolism, and Gut Microbiota Function in High-Fat and High-Cholesterol Diet-Challenged Layer Chickens.

Effects of Dietary Inclusion of β-Hydroxy-β-Methylbutyrate on Growth Performance, Fat Deposition, Bile Acid Metabolism, and Gut Microbiota Function in High-Fat and High-Cholesterol Diet-Challenged Layer Chickens.

Journal: Current issues in molecular biology

Published: June 23, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026